Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination

Chronic demyelination is a pathological hallmark of multiple sclerosis (MS). Only a minority of MS lesions remyelinates completely. Enhancing remyelination is, therefore, a major aim of future MS therapies. Here we took a novel approach to identify factors that may inhibit or support endogenous remy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Hema, Friese, Anita, Albrecht, Stefanie, Krumbholz, Markus, Elliott, Christina L, Arthur, Ariel, Menon, Ramesh, Farina, Cinthia, Junker, Andreas, Stadelmann, Christine, Barnett, Susan C, Huitinga, Inge, Wekerle, Hartmut, Hohlfeld, Reinhard, Lassmann, Hans, Kuhlmann, Tanja, Linington, Chris, Meinl, Edgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359505/
https://www.ncbi.nlm.nih.gov/pubmed/25589163
http://dx.doi.org/10.1186/s40478-014-0168-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359505/
https://www.ncbi.nlm.nih.gov/pubmed/25589163
http://dx.doi.org/10.1186/s40478-014-0168-9

Ejemplares similares